HARVARD BIOSCIENCE, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Amount
HARVARD BIOSCIENCE, INC. (HBIO) reported Effective Income Tax Rate Reconciliation, Tax Credit, Amount of $507.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxCredits · last filed 2026-03-13
- HARVARD BIOSCIENCE, INC. effective income tax rate reconciliation, tax credit, amount for fiscal 2025 was $507.00K.
- HARVARD BIOSCIENCE, INC. effective income tax rate reconciliation, tax credit, amount for fiscal 2022 was $492.00K, a 8.13% increase from fiscal 2021.
- HARVARD BIOSCIENCE, INC. effective income tax rate reconciliation, tax credit, amount for fiscal 2021 was $455.00K, a 136.98% increase from fiscal 2020.
- HARVARD BIOSCIENCE, INC. effective income tax rate reconciliation, tax credit, amount for fiscal 2020 was $192.00K, a 12.73% decline from fiscal 2019.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Amount 12 month | Effective Income Tax Rate Reconciliation, Tax Credit, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $507.00K 10-K · filed 2026-03-13 | |
| 2022-12-31 | $492.00K 10-K · filed 2023-03-09 | |
| 2021-12-31 | $455.00K 10-K · filed 2023-03-09 | |
| 2020-12-31 | $192.00K 10-K · filed 2022-03-11 | |
| 2019-12-31 | $220.00K 10-K/A · filed 2021-03-17 | |
| 2018-12-31 | $242.00K 10-K · filed 2019-03-18 | |
| 2017-12-31 | $14.00K 10-K · filed 2019-03-18 | -$14.00K 10-K · filed 2018-03-16 |
| 2016-12-31 | -$89.00K 10-K · filed 2018-03-16 | |
| 2015-12-31 | -$169.00K 10-K · filed 2018-03-16 | |
| 2014-12-31 | -$385.00K 10-K · filed 2017-03-17 | |
| 2013-12-31 | -$615.00K 10-K · filed 2016-04-29 | |
| 2012-12-31 | -$127.00K 10-K · filed 2015-03-12 | |
| 2011-12-31 | -$558.00K 10-K · filed 2014-03-14 | -$231.00K 10-K · filed 2013-03-18 |
| 2010-12-31 | -$279.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |